Janice Kew Bloomberg
- All
- News
-
Mysterious 'Disease X' Outbreak Widens, UN Sends Health Team To Congo
More cases of a mysterious flu-like illness labeled "Disease X" were reported in the Democratic Republic of the Congo.
-
Pfizer Shots, Prior Infection May Protect Better vs Omicron: Scientists
A two-dose course of Pfizer Inc. and BioNTech SE's Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists from the Africa Health Research Institute in South Africa said.
-
Omicron Symptoms Far Milder Than First Three Waves: South Africa Expert
Netcare is seeing milder Covid-19 cases even as omicron is driving up the number of people testing positive for the virus.
-
As Omicron Spreads, Mixed Messages About How Dangerous It Can Be
South Africa's surge in Covid-19 cases following the emergence of the omicron variant hasn't overwhelmed hospitals so far, prompting some cautious optimism that the new strain may cause mostly mild illness.
-
Omicron Epicentre: Symptoms And Condition Of Infected Patients
Initial data from a major hospital complex in South Africa's omicron epicenter show that while Covid-19 case numbers have surged, patients need less medical intervention.
-
New Covid Variant Has "Unusually Large" Number Of Mutations: WHO
World Health Organization officials met on Thursday to discuss a new coronavirus variant circulating in South Africa and Botswana.
-
New Weight-Loss Medicine That Dampens Appetite Is Flying Off The Shelves
In a field starved for options, demand is exceeding supply for Wegovy, a weekly injection launched in June that dampens patients' appetite and helps them to lose about 15 per cent of their body weight.
-
"Colonialist Mentality": Rising Backlash Over UK Vaccine Policy
The UK government is facing a rising backlash over its refusal to recognize visitors as vaccinated unless they received their shots in a handful of select countries.
-
Longer 8-Week Gap Between Pfizer Doses Boosts Antibodies, Study Finds
An interval of eight to 10 weeks between doses of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE boosts the effectiveness of the two-shot regimen compared with a shorter interval, a U.K. study found.
-
Mysterious 'Disease X' Outbreak Widens, UN Sends Health Team To Congo
More cases of a mysterious flu-like illness labeled "Disease X" were reported in the Democratic Republic of the Congo.
-
Pfizer Shots, Prior Infection May Protect Better vs Omicron: Scientists
A two-dose course of Pfizer Inc. and BioNTech SE's Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists from the Africa Health Research Institute in South Africa said.
-
Omicron Symptoms Far Milder Than First Three Waves: South Africa Expert
Netcare is seeing milder Covid-19 cases even as omicron is driving up the number of people testing positive for the virus.
-
As Omicron Spreads, Mixed Messages About How Dangerous It Can Be
South Africa's surge in Covid-19 cases following the emergence of the omicron variant hasn't overwhelmed hospitals so far, prompting some cautious optimism that the new strain may cause mostly mild illness.
-
Omicron Epicentre: Symptoms And Condition Of Infected Patients
Initial data from a major hospital complex in South Africa's omicron epicenter show that while Covid-19 case numbers have surged, patients need less medical intervention.
-
New Covid Variant Has "Unusually Large" Number Of Mutations: WHO
World Health Organization officials met on Thursday to discuss a new coronavirus variant circulating in South Africa and Botswana.
-
New Weight-Loss Medicine That Dampens Appetite Is Flying Off The Shelves
In a field starved for options, demand is exceeding supply for Wegovy, a weekly injection launched in June that dampens patients' appetite and helps them to lose about 15 per cent of their body weight.
-
"Colonialist Mentality": Rising Backlash Over UK Vaccine Policy
The UK government is facing a rising backlash over its refusal to recognize visitors as vaccinated unless they received their shots in a handful of select countries.
-
Longer 8-Week Gap Between Pfizer Doses Boosts Antibodies, Study Finds
An interval of eight to 10 weeks between doses of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE boosts the effectiveness of the two-shot regimen compared with a shorter interval, a U.K. study found.
